Table 4.
Inhibition kinetic parameter estimates | |||||
---|---|---|---|---|---|
Item | 2 | 3 | 4 | 5 | |
Cellulase activity (nmol/mg protein·min) | |||||
GH5-tCel5A1 | 7.21 | 0.37 | 7.57 | 1.59 | |
Heated GH5-tCel5A1 | 11.84 | 3.34 | 15.18 | 0.99 | |
GH5-p4818Cel5_2A | 108.51 | 1.12 | 109.63 | 1.19 | |
Relative cellulase activity (% of the control)6 | |||||
GH5-tCel5A1 | 95.18 | 4.82 | 100.00 | 1.59 | |
Heated GH5-tCel5A1 | 78.01 | 21.98 | 100.00 | 1.00 | |
GH5-p4818Cel5_2A | 98.98 | 1.02 | 100.00 | 1.20 |
1Values are parameter estimates or means SE (n = 72) obtained through the Eadie-Hofstee regression linear analyses, representing the inhibition kinetic parameter estimates obtained from the three chymotrypsin (20 U/mL) inhibition experiments with 4 replicates per time point in each experiment, as shown in Figs. 15, 16, 17.
2 is the maximal magnitude of inhibition in the cellulase activity (nmol/mg protein·min or % of the control, means SE, n = 12) calculated according to Eq. (2).
3 is the minimal residual cellulase activity (nmol/mg protein·min or % of the control Ic; parameter estimate SE, n = 72) under the intestinal chymotrypsin (20 U/mL) inhibition condition obtained from Eq. (1).
4 is the mean cellulase activity of the control group (nmol/mg protein·min or % of the control, means SE, n = 12).
5 is the incubation time (h, parameter estimate SE, n = 72) required to reach the half maximal inhibition of the cellulase activity.
6Relative cellulase activity calculated as percentage (%, means SE, n = 12) of the control group (Ic) measured at 0-min exposure to the intestinal chymotrypsin (20 U/mL) incubation.